Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a very long-term experience of Polish Hypereosinophilic Syndrome Study Group | Zendy

AI Assistant Blog Pricing

Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a very long-term experience of Polish Hypereosinophilic Syndrome Study Group

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.